PMID- 22275073 OWN - NLM STAT- MEDLINE DCOM- 20121011 LR - 20211021 IS - 1097-4644 (Electronic) IS - 0730-2312 (Print) IS - 0730-2312 (Linking) VI - 113 IP - 4 DP - 2012 Apr TI - Matrix metalloproteinase-9 in homocysteine-induced intestinal microvascular endothelial paracellular and transcellular permeability. PG - 1159-69 LID - 10.1002/jcb.23451 [doi] AB - Although elevated levels of homocysteine (Hcy), known as hyperhomocysteinemia (HHcy), is associated with inflammatory bowel disease (IBD), the mechanism of Hcy action is unclear. In the present study, we tested the hypothesis that HHcy activates matrix metalloproteinase-9 (MMP-9), which in turn enhances permeability of human intestinal microvascular endothelial cell (HIMEC) layer by decreasing expression of endothelial junction proteins and increasing caveolae formation. HIMECs were grown in Transwells and treated with 500 microM Hcy in the presence or absence of MMP-9 activity inhibitor. Hcy-induced permeability to FITC-conjugated bovine serum albumin (FITC-BSA) was assessed by measuring fluorescence intensity of solutes in the Transwells' lower chambers. The cell-cell interaction and cell barrier function was estimated by measuring trans-endothelial electrical impedance. Confocal microscopy and flow cytometry were used to study cell junction protein expressions. Hcy-induced changes in transcellular transport of HIMECs were estimated by observing formation of functional caveolae defined as caveolae labeled by cholera toxin and antibody against caveolin-1 and one that have taken up FITC-BSA. Hcy instigated HIMEC monolayer permeability through activation of MMP-9. The increased paracellular permeability was associated with degradation of vascular endothelial cadherin and zona occludin-1 and transcellular permeability through increased caveolae formation in HIMECs. Elevation of Hcy content increases permeability of HIMEC layer affecting both paracellular and transcellular transport pathways, and this increased permeability was alleviated by inhibition of MMP-9 activity. These findings contribute to clarification of mechanisms of IBD development. CI - (c) 2011 Wiley Periodicals, Inc. FAU - Munjal, Charu AU - Munjal C AD - Department of Physiology and Biophysics, University of Louisville School of Medicine, Louisville, KY 40202, USA. FAU - Tyagi, Neetu AU - Tyagi N FAU - Lominadze, David AU - Lominadze D FAU - Tyagi, Suresh C AU - Tyagi SC LA - eng GR - HL-80394/HL/NHLBI NIH HHS/United States GR - R01 HL080394/HL/NHLBI NIH HHS/United States GR - R01 NS051568-05/NS/NINDS NIH HHS/United States GR - R01 HL071010/HL/NHLBI NIH HHS/United States GR - R01 NS051568/NS/NINDS NIH HHS/United States GR - NS-51568/NS/NINDS NIH HHS/United States GR - HL-74185/HL/NHLBI NIH HHS/United States GR - HL-71010/HL/NHLBI NIH HHS/United States GR - R01 HL074185/HL/NHLBI NIH HHS/United States GR - R01 HL071010-08/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - United States TA - J Cell Biochem JT - Journal of cellular biochemistry JID - 8205768 RN - 0 (Actins) RN - 0 (Membrane Proteins) RN - 0 (Phosphoproteins) RN - 0 (TJP1 protein, human) RN - 0 (Zonula Occludens-1 Protein) RN - 0LVT1QZ0BA (Homocysteine) RN - EC 3.4.24.35 (Matrix Metalloproteinase 9) SB - IM MH - Actins/biosynthesis MH - Cells, Cultured MH - Endothelium, Vascular/enzymology/*metabolism MH - Enzyme Activation MH - Flow Cytometry MH - Homocysteine/*metabolism MH - Humans MH - Immunohistochemistry MH - Intestines/*blood supply/enzymology MH - Matrix Metalloproteinase 9/*metabolism MH - Membrane Proteins/metabolism MH - Microvessels/enzymology/*metabolism MH - Permeability MH - Phosphoproteins/metabolism MH - Tight Junctions MH - Zonula Occludens-1 Protein PMC - PMC3337944 MID - NIHMS342134 EDAT- 2012/01/26 06:00 MHDA- 2012/10/12 06:00 PMCR- 2013/04/01 CRDT- 2012/01/26 06:00 PHST- 2012/01/26 06:00 [entrez] PHST- 2012/01/26 06:00 [pubmed] PHST- 2012/10/12 06:00 [medline] PHST- 2013/04/01 00:00 [pmc-release] AID - 10.1002/jcb.23451 [doi] PST - ppublish SO - J Cell Biochem. 2012 Apr;113(4):1159-69. doi: 10.1002/jcb.23451.